Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study

Recently, dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors have been very often used in subjects with type 2 diabetes mellitus (T2DM). In addition, combination drugs of both inhibitors have attracted much attention in aspects of its cost-effectiveness a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fushimi, Yoshiro, Obata, Atsushi, Sanada, Junpei, Iwamoto, Yuichiro, Mashiko, Akiko, Horiya, Megumi, Mizoguchi-Tomita, Akiko, Nishioka, Momoyo, Kan, Yuki, Kinoshita, Tomoe, Okauchi, Seizo, Hirukawa, Hidenori, Kohara, Kenji, Tatsumi, Fuminori, Shimoda, Masashi, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154962/
https://www.ncbi.nlm.nih.gov/pubmed/32337293
http://dx.doi.org/10.1155/2020/4861681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154962/
https://www.ncbi.nlm.nih.gov/pubmed/32337293
http://dx.doi.org/10.1155/2020/4861681

Ejemplares similares